DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Gheorghiade M, Gattis WA, O’Connor CM, Adams KF jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C.
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
JAMA 2004; 291: 1963-1971
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.